What the Latest Dronabinol PTSD Nightmares Clinical Trial Reveals
A recent dronabinol PTSD nightmares clinical trial involving 171 adults demonstrated that this FDA-approved synthetic THC medication significantly reduces nightmare frequency and intensity. The trial highlights dronabinol's targeted effect on…
Clinical Efficacy of Dronabinol for PTSD Nightmares: Insights from a 171-Person Trial
A 171-person randomized controlled trial demonstrates dronabinol PTSD nightmares clinical efficacy, significantly reducing nightmare frequency and intensity. This FDA-approved synthetic THC medication offers targeted relief for PTSD-related nightmares…
Dronabinol Cuts PTSD Nightmares in a New Randomized Trial
Dronabinol PTSD nightmares: a randomized, placebo-controlled trial in more than 170 adults found nightly oral THC significantly reduced PTSD-related nightmares over 10 weeks. More than a third of treated patients became nightmare-free. Overall PTSD…
PTSD and Solitary Substance Use: Different Risks for Alcohol and Cannabis
A recent study reveals that PTSD solitary alcohol use risk is significantly linked to increased alcohol-related problems, unlike solitary cannabis use. This finding challenges assumptions that all solitary substance use carries the same risk for those…
THC and PTSD: Insights from a Dose-Finding Clinical Trial on Cognitive Reappraisal
A THC dose-finding clinical trial standardized in adults with PTSD revealed dose-dependent reductions in prefrontal brain activity during cognitive reappraisal. Despite these neural changes, self-reported emotional ratings remained unchanged. This…
THC and PTSD Emotion Regulation: What a New Brain-Imaging Study Actually Found
The acute oral THC cognitive reappraisal PTSD study found that 5 mg and 10 mg doses reduced prefrontal brain activation during emotion regulation in adults with PTSD. Despite these neural changes, no improvement in self-reported negative affect was…
What 26 Studies and 3,598 Patients Reveal About Cannabis and PTSD
This medical cannabis PTSD scoping review examines 26 studies and 3,598 patients. The controlled-trial evidence did not support broad PTSD symptom benefit, with one narrow signal for nabilone and nightmares. The article explains what the review shows,…
Can cannabis treat depression and anxiety? Here’s what researchers found – MSN
✦ New CED Clinical Relevance #68 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthAnxietyResearchCBDTHCSafetyPTSD Why This Matters Clinicians need to understand the current evidence on…
Normalizing marijuana use harms foster kids mental health | Opinion – The Arizona Republic
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthPolicyPediatricsSafetyTHCAnxietyResearch Why This Matters Clinicians treating former foster youth need…
Advocates Call for Wider Access to Medical Cannabis in Women’s Health Conditions
✦ New CED Clinical Relevance #76 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchPolicyAnxietyPTSDWomen’s HealthSafety Why This Matters Clinicians treating women with…